Immorta Bio, Inc., a biotechnology company pioneering therapies targeting fundamental mechanisms of aging, today announced ...
MAINZ, Germany, October 13, 2026 - BioNTech SE (Nasdaq: BNTX, "BioNTech” or "the Company”) today announced the first topline results from the AHEAD-MERIT Phase 2/3 clinical trial (NCT04534205) for its ...
Morning Overview on MSN
33 months after immunotherapy replaced chemo, none of 32 bowel-cancer patients had relapsed
Dr. Kai-Keen Shiu, the chief investigator of a London bowel-cancer trial, says the lack of any recurrence after almost three ...
Cosibelimab (Unloxcyt; Sun Pharma), a PD-L1 inhibitor, is also approved for locally advanced and metastatic cutaneous ...
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the ...
High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous ...
In patients with severe peanut allergy, adding abatacept to oral immunotherapy does not significantly suppress the increase in peanut-specific IgE levels, but anaphylaxis may occur less often.
Blood cancers or leukemias are not a single disease. In fact, the same type of cancer may behave differently in two ...
Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to ...
Experts will discuss emerging approaches for profiling the tumor microenvironment, identifying neoantigens, developing cell ...
Prop 38 aims to fund immunotherapy research to prevent and cure diseases through bonds. An opponent says it is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results